medigraphic.com
ISSN 1684-1824 (Electronic)

2020, Number 1

<< Back Next >>

Rev Méd Electrón 2020; 42 (1)

Avances actuales en la reducción de los factores de riesgo cardiovasculares

Arredondo BAE, de Quezada LF, Guerrero JG

Language: Spanish
References: 25
Page:
PDF size: 136.26 Kb.


ABSTRACT

The increment of the cardiovascular illnesses, together with the high costs that this bears, it has identified the necessity of a renovation in the focus of the reduction of the cardiovascular risks in the arterial hypertension. Was carried out a bibliographical revision about the cardiovascular factors risk of in English and Spanish of the main articles published in PubMed, Scielo and MEDLINE during the last five years. Develop and. Although achievements have been reached, the reduction of the cardiovascular illnesses through the modification of the lifestyles continues being a challenge. Most of the patients continue taking an inadequate lifestyle, and less than the population's 1 % observes the seven essential points that measure a healthy life. Although the cardiovascular health will require of a wide focus to elimination the risk factors based on the promotion of healthy behaviors for life, this needs of the local government's enormous effort, the sanitary authorities, and mainly of the local teams of health.


REFERENCES

  1. Williams KA, Alexander S, Patel HN. The State of the Art in Cardiovascular Risk Reduction. Medscape [Internet]; 2018 [citado 10/02/ 2019]; Disponible en: https://www.medscape.com/viewarticle/892927

  2. Peralta C, Loayza K, Medina-Palomino F, et al. Monitoreo domiciliario de presión arterial y factores de riesgo cardiovascular en jóvenes estudiantes de medicina de una universidad privada en Lima, Perú. Rev Med Hered [Intenet] 2017 [citado 10/02/ 2019] ;28 (3): Disponible en: http://dx.doi.org/https://doi.org/10.20453/rmh.v28i3.3182

  3. CDC. Vital Signs: Preventable Deaths from Heart Disease & Stroke. Last updated: [Internet]; 2014[citado 10/02/2019]; Disponible en: https://www.cdc.gov/dhdsp/vital_signs.htm

  4. AHA. Heart Disease and Stroke Statistics–2017 Update: A Report From American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. .Citado en Pub Med;PIMD:28122885

  5. Ministerio de Salud Pública. Anuario Estadístico de Salud 2017[Internet]. La Habana: Ministerio de Salud Pública[citado 10/02/2019]; 2018. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  6. Alfonso Prínce JC, Salabert Tortoló I, Alfonso Salabert I, et al. La hipertensión arterial: un problema de salud internacional. Rev Med Electrón [Internet]. 2017 [citado 10/02/2019]; 39(4). Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242017000400013&lng=es

  7. Benjamin WG, Blaha EJ, Chiuve MJ, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146. Citado en PubMed;PMID: 5408160.

  8. American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes—2018. Diabetes Care [Internet] 2018 [citado 10/02/2019] ; 41(Supp 1): S86-S104. Disponible en: http://care.diabetesjournals.org/content/41/Supplement_1/S86

  9. CDC. Million Hearts: Meaningful Progress 2012-2016—A Final Report. [Internet]; 2017[citado 10/2/2019]; Disponible en: https://millionhearts.hhs.gov/files/MHmeaningful- progress.pdf

  10. Arredondo Bruce A, García Velázquez E, Pons Vázquez R, et al. La pre hipertensión en el vórtice de las enfermedades cardiovasculares. Rev Med Electron [Internet]. 2014 [citado 10/02/2019]; 36( Suppl 1): 729-41. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242014000700006&lng=es

  11. Whelton PK, Carey RM, Aronow WS. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. J Am Soc Hypertens. 2018 Aug;12(8):579.e1-579.e73. Citado en PubMed: PMID: 30219548.

  12. Stergiou GS, Palatini P, Asmar R, et al. Blood pressure monitoring: theory and practice. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability Teaching Course Proceedings. Blood Press Monit 2018;23(1): 1-8. Citado en PubMed: PMID:29189213.

  13. CDC. CDC health disparities and inequalities report-United States, 2016. MMWR [Internet] 2016 [citado 06/01/2019]; 65 (Suppl Nº1). Disponible en: https://www.cdc.gov/minorityhealth/strategies2016/index.html

  14. Pérez Caballero M D, León Álvarez J L, Dueñas Herrera A, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev Cub Med Int [Internet];2017 [citado 10/02/ 2019]; 56. Disponible en: http://bvs.sld.cu/revistas/med/vol56_sup_17/sumario.htm

  15. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol[Internet] 2019[citado 10/02/ 2019];73(24):3168-3209. Disponible en: https://www.acc.org/~/media/Non- Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2018/Guidelines-Made-Simple-Tool- 2018-Cholesterol.pdf

  16. Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2017 Focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on expert consensus decision pathways. J Am Coll Cardiol [Internet] 2017 [citado 10/02/2019] 23976. Disponible en: http://www.onlinejacc.org/content/early/2017/08/30/j.jacc.2017.07.745

  17. Abdul-Ghani M, DeFronzo RA, Del Prato S, et al. Cardiovascular disease and type 2 diabetes: has the dawn of a new era arrived? Diabetes Care [Internet] 2017 [citado 10/02/ 2019] ; 40(7): 813-20. Disponible en: http://care.diabetesjournals.org/content/40/7/813

  18. Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiology 2017;2(7): 775-81. Citado en PubMed;PMID:28564682

  19. Wei M, Brandhorst S, Shelehchi M, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 2017; 9(377). Citado en PUbMed;PMID: 28202779

  20. Patnode C D, Evans C V, Senger C A, et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. Jama 2017; 318(2): 175-93. Citado en PUbMed;PMID:28697259.

  21. Yokoyama Y, Nishimura K, Barnard ND. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med 2014; ;174(4):577-87. Citado en PUbMed;PMID:24566947

  22. Panizza C E, Shvetsov Y B, Harmon B E, et al. Testing the Predictive Validity of the Healthy Eating Index-2015 in the Multiethnic Cohort: Is the Score Associated with a Reduced Risk of All-Cause and Cause-Specific Mortality? Nutrients 2018; 10(4): 452. Citado en PUbMed;PMID: 29621192

  23. Lear SA, Hu W, Rangarajan S. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet 2017;390(10113):2643-54. Citado en PUbMed;PMID:28943267

  24. CDC. Fast Facts and Fact Sheets: Current cigarette smoking among adults in the United States[Internet]. USA:CDC[citado 06/01/ 2018]; 2017. Disponible en: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/index.htm

  25. Vidal-Petiot E, Stebbins A, Chiswell K, et al. Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease: insights from the STABILITY trial. Eur Heart J 2017;38(37):2813–22. Citado en Pub Med; PMID:28575274.




2020     |     www.medigraphic.com